Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report

Ann Rheum Dis. 2022 Feb;81(2):e20. doi: 10.1136/annrheumdis-2020-216983. Epub 2020 Feb 13.
No abstract available

Keywords: inflammation; juvenile idiopathic arthritis; pulmonary fibrosis.

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Juvenile* / drug therapy
  • Humans
  • Immunotherapy
  • Lung Diseases, Interstitial* / drug therapy
  • Nitriles
  • Pyrazoles / adverse effects
  • Pyrimidines

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib